 | | Amprenavir (Agenerase) |  | | Published
January 25, 2001; Updated
December 04, 2007 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-05 | | | Selected Reference | | 2. | Discontinuation of Agenerase (amprenavir) Oral Solution and 50 mg Capsules in the US. Dear Healthcare Professional. GlaxoSmithKline: Research Triangle Park, North Carolina, August 2007. Available online at http://www.fda.gov/CDER/Drug/shortages/AGN-DC%20DHP%20Letter.pdf. | |
|
|
|
